Recalls / Active ingredient / Bempedoic Acid
Bempedoic Acid
2 FDA drug recalls involving the active ingredient “Bempedoic Acid”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-03-27 | Class III | NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esp | Esperion |
| 2023-08-16 | Class III | Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeut | Esperion |